Use of molecular maging markers of glycolysis, hypoxia and proliferation (18F-FDG, 64Cu-ATSM and 18F-FLT) in a dog with fibrosarcoma: the importance of individualized treatment planning and monitoring

Kamilla Westarp Zornhagen; Malene Martini Clausen; Anders E. Hansen; Ian Law; Fintan McEvoy; Svend Aage Engelholm; Andreas Kjær; Annemarie Thuri Kristensen

doi:10.3390/diagnostics5030372

Use of molecular maging markers of glycolysis, hypoxia and proliferation (¹⁸F-FDG, ⁶⁴Cu-ATSM and ¹⁸F-FLT) in a dog with fibrosarcoma: the importance of individualized treatment planning and monitoring

Kamilla Westarp Zornhagen, Malene Martini Clausen, Anders E. Hansen, Ian Law, Fintan McEvoy, Svend Aage Engelholm, Andreas Kjær, Annemarie Thuri Kristensen

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

3 Citationer (Scopus)

262 Downloads (Pure)

Originalsprog	Engelsk
Tidsskrift	Diagnostics
Vol/bind	5
Udgave nummer	3
Sider (fra-til)	372-382
Antal sider	11
ISSN	2075-4418
DOI	https://doi.org/10.3390/diagnostics5030372
Status	Udgivet - 11 sep. 2015

Adgang til dokumentet

10.3390/diagnostics5030372Licens: Andet

Use of molecular maging markers of glycolysis, hypoxia and proliferation (18F-FDG, 64Cu-ATSM and 18F-FLT) in a dog with fibrosarcomaForlagets udgivne version, 1,26 MB

Citationsformater

Zornhagen, K. W., Clausen, M. M., Hansen, A. E., Law, I., McEvoy, F., Engelholm, S. A., Kjær, A., & Kristensen, A. T. (2015). Use of molecular maging markers of glycolysis, hypoxia and proliferation (¹⁸F-FDG, ⁶⁴Cu-ATSM and ¹⁸F-FLT) in a dog with fibrosarcoma: the importance of individualized treatment planning and monitoring. Diagnostics, 5(3), 372-382. https://doi.org/10.3390/diagnostics5030372

Use of molecular maging markers of glycolysis, hypoxia and proliferation (¹⁸F-FDG, ⁶⁴Cu-ATSM and ¹⁸F-FLT) in a dog with fibrosarcoma: the importance of individualized treatment planning and monitoring. / Zornhagen, Kamilla Westarp ; Clausen, Malene Martini; Hansen, Anders E. et al.
I: Diagnostics, Bind 5, Nr. 3, 11.09.2015, s. 372-382.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Zornhagen, KW , Clausen, MM, Hansen, AE, Law, I , McEvoy, F, Engelholm, SA, Kjær, A & Kristensen, AT 2015, 'Use of molecular maging markers of glycolysis, hypoxia and proliferation (¹⁸F-FDG, ⁶⁴Cu-ATSM and ¹⁸F-FLT) in a dog with fibrosarcoma: the importance of individualized treatment planning and monitoring', Diagnostics, bind 5, nr. 3, s. 372-382. https://doi.org/10.3390/diagnostics5030372

@article{8782506ea22d469d932a7ef24869793e,

title = "Use of molecular maging markers of glycolysis, hypoxia and proliferation (18F-FDG, 64Cu-ATSM and 18F-FLT) in a dog with fibrosarcoma: the importance of individualized treatment planning and monitoring",

author = "Zornhagen, {Kamilla Westarp} and Clausen, {Malene Martini} and Hansen, {Anders E.} and Ian Law and Fintan McEvoy and Engelholm, {Svend Aage} and Andreas Kj{\ae}r and Kristensen, {Annemarie Thuri}",

year = "2015",

month = sep,

day = "11",

doi = "10.3390/diagnostics5030372",

language = "English",

volume = "5",

pages = "372--382",

journal = "Diagnostics",

issn = "2075-4418",

publisher = "MDPI AG",

number = "3",

}

TY - JOUR

T1 - Use of molecular maging markers of glycolysis, hypoxia and proliferation (18F-FDG, 64Cu-ATSM and 18F-FLT) in a dog with fibrosarcoma

T2 - the importance of individualized treatment planning and monitoring

AU - Zornhagen, Kamilla Westarp

AU - Clausen, Malene Martini

AU - Hansen, Anders E.

AU - Law, Ian

AU - McEvoy, Fintan

AU - Engelholm, Svend Aage

AU - Kjær, Andreas

AU - Kristensen, Annemarie Thuri

PY - 2015/9/11

Y1 - 2015/9/11

U2 - 10.3390/diagnostics5030372

DO - 10.3390/diagnostics5030372

M3 - Journal article

C2 - 26854160

SN - 2075-4418

VL - 5

SP - 372

EP - 382

JO - Diagnostics

JF - Diagnostics

IS - 3

ER -